Companies in #Gastroenterology

Cumberland Pharmaceuticals is a U.S. specialty pharmaceutical company focused on acquiring, developing, and commercializing prescription products for hospital acute-care and gastroenterology. Founded in Nashville in 1999, the company markets brands including Acetadote, Caldolor, Kristalose, and Vibativ. In 2026 it completed a $100 million strategic transaction with an affiliate of Apotex, the largest Canadian pharmaceutical company, in which Apotex acquired Cumberland's line of branded pharmaceuticals at closing (July 1, 2026), funded a special shareholder dividend, and sharpened Cumberland's focus on its late-stage orphan-drug pipeline, including ifetroban and a Duchenne muscular dystrophy candidate holding FDA orphan and rare pediatric disease designations.

Swiss medtech company developing implantable medical devices for chronic conditions. Lead product RefluxStop is an FDA-approved and CE-marked implant for the treatment of gastroesophageal reflux disease (GERD).

Italian pharmaceutical company specializing in biologics, CDMO services, and specialty pharmaceuticals. Active in European and global markets with recent expansion into obesity therapeutics via GLP-1 licensing deals.

Nitinotes is a medical devices company. See today's news for the latest developments.